Sonothrombolysis is effective with recombinant tissue-type plasminogen activator, but not with Abciximab

Summary

Transcranial “diagnostic” ultrasound (US) has been shown to accelerate thrombolysis related to recombinant tissue-type plasminogen activator (rt-PA). In this in vitro study, we evaluated the potential of US to increase clot dissolution mediated by Abciximab (Abc) compared to rt-PA. The effect of 1.8-MHz pulsed wave (PW) Doppler US on dissolution of whole venous blood clots (WBC) and platelet-rich clots (PRC) treated with Abc and rt-PA was investigated in an in vitro model. Clot dissolution was measured by weight loss. Abc-related WBC dissolution was enhanced by additional US, but the effect was not any more detectable when the US was attenuated by a human temporal bone (US-tb). In PRC there was no additional effect of US on the Abc-related clot lysis. Rt-PA-related clot dissolution was increased by US in WBC and PRC as well, however, US-tb was only effective in WBC. The effect of insonation on WBC dissolution treated with the combination of Abc plus rt-PA was lower compared with those treated with rt-PA. In this in vitro experiment, the additional effect of “diagnostic” US in combination with Abc was only present in WBC and less strong than with rt-PA. The results do not support the use of Abc for sonothrombolysis targeting both, fibrin-rich and platelet-rich clots. In contrast, US when combined with rt-PA increases dissolution in both, WBC and PRC as well.

Keywords

Transcranial Doppler ultrasound - thrombolysis - stroke

• References

• 1 Alexandrov AV, Molina CA, Grotta JC. et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178.
• 2 Eggers J, Koch B, Meyer K. et al. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol 2003; 53: 797-800.
• 3 Eggers J, König IR, Koch B. et al. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator rt-PA in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke 2008; 39: 1470-1475.
• 4 Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 1997; 78: 1063-1068.
• 5 Siddiqi F, Blinc A, Braaten J, Francis CW. Ultrasound increases flow through fibrin gels. Thromb Haemost 1995; 73: 495-498.
• 6 Siddiqi F, Odrljin TM, Fay PJ. et al. Binding of tissue-plasminogen activator to fibrin: effect of ultrasound. Blood 1998; 91: 2019-2025.
• 7 Devcic-Kuhar B, Pfaffenberger S, Gherardini L. et al. Ultrasound affects distribution of plasminogen and tissue-type plasminogen activator in whole blood clots in vitro. Thromb Haemost 2004; 92: 980-985.
• 8 Pfaffenberger S, Devcic-Kuhar B, El-Rabadi K. et al. 2MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves. Thromb Haemost 2003; 89: 583-589.
• 9 Basta G, Lupi C, Lazzerini G. et al Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. An in vitro study on blood of normal subjects and patients with coronary artery disease. Thromb Haemost 2004; 91: 1078-1083.
• 10 Eggers J, Ossadnik S, Seidel G. Enhanced clot dissolution in vitro by 1.8-MHz pulsed ultrasound. Ultrasound Med Biol 2009; 35: 523-526.
• 11 Seitz RJ, Meisel S, Moll M. et al. The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology 2004; 62: 2110-2112.
• 12 Eckert B, Koch C, Thomalla G, Kucinski T. et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005; 36: 1160-1165.
• 13 Nagel S, Schellinger PD, Hartmann M. et al. Therapy of acute basilar artery occlusion. Intraarterial thrombolysis alone vs bridging therapy. Stroke 2009; 40: 140-146.
• 14 Mager DE, Mascelli MA, Kleiman NS. et al. Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty. J Pharmacol Exp Ther 2003; 307: 969-976.
• 15 Quinn MJ, Murphy RT, Dooley M. et al. Occupancy of the internal and external pools of glycoprotein IIb/IIIa following abciximab bolus and infusion. J Pharmacol Exp Ther 2001; 297: 496-500.
• 16 Semba CP, Weck S, Patapoff T. Alteplase: stability and bioactivity after dilution in normal saline solution. J Vasc Interv Radiol 2003; 14: 99-102.
• 17 Furman MI, Frelinger 3rd AL, Michelson AD. GPIIb/IIIa inhibitor-induced dethrombosis. J Thromb Thrombolysis 2004; 18: 11-17.
• 18 Atar S, Luo H, Birnbaum Y. et al. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs. J Thromb Thrombolysis 2001; 11: 223-228.
• 19 Meunier JM, Holland CK, Pancioli AM. et al. Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots. Thromb Res 2009; 123: 528-536.
• 20 Huang TC, Jordan RE, Hantgan RR. et al. Differential effects of c7E3 Fab on thrombus formation and rt- PA-mediated thrombolysis under flow conditions. Thromb Res 2001; 102: 411-425.
• 21 Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res 2004; 114: 447-453.
• 22 Choudhri TF, Hoh BL, Zerwes HG. et al. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptormediated platelet aggregation. J Clin Invest 1998; 102: 1301-1310.